Global Insulin Pens, Syringes, Pumps And Injectors Market Scope 2024, Forecast To 2033
12 Jan, 2024
The market for insulin delivery devices has seen strong growth, increasing from $23.3 billion in 2023 to $25.36 billion in 2024, with an 8.8% CAGR. Historical growth drivers include rising diabetes prevalence, advancements in insulin delivery, patient preference for convenience, and an aging population. The forecast projects continued strong growth, reaching $34.41 billion in 2028, with a 7.9% CAGR. Ongoing factors include growth in emerging markets, regulatory support, personalized medicine, and value-based healthcare. Emerging trends include artificial intelligence (AI) integration, handheld and wireless ultrasound devices, 3D/4D imaging, and fusion imaging.
Global Insulin Pens, Syringes, Pumps And Injectors Market Key Driver
The global rise in diabetes prevalence propels growth in the market for insulin pens, syringes, pumps, and injectors. Unhealthy lifestyles contribute to a surge in obesity, causing an uptick in diabetes cases. In 2020, the US CDC reported 34.2 million Americans with diabetes. The International Diabetes Federation estimates 537 million adults globally lived with diabetes in 2021, projected to reach 783 million by 2045. This escalating diabetes prevalence fuels demand for insulin delivery devices.
Get A Free Sample Of The Global Insulin Pens, Syringes, Pumps And Injectors Market ReportGlobal Insulin Pens, Syringes, Pumps And Injectors Market Segments
The insulin pens, syringes, pumps and injectors market covered in this report is segmented –
1)By Type: Pens, Injectors And Pumps, Syringes
2)By Pens: Reusable, Disposable
3)By Pumps: Tubed Pumps, Tubeless Pumps
4)By End Users: Hospitals, Homecare, Other End Users
By Geography: The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2023. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Insulin Pens, Syringes, Pumps And Injectors Industry Players
Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.
Get The Full Global Insulin Pens, Syringes, Pumps And Injectors Market Report
Insulin Pens, Syringes, Pumps And Injectors Market Overview
Insulin pens, syringes, pumps, and injectors are used to administer insulin to diabetic patients to control blood glucose levels. These devices are reusable or disposable tools used to inject the desired dose of insulin into the blood of a diabetic patient.
Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2023 provides data on the global insulin pens, syringes, pumps and injectors market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The insulin pens, syringes, pumps and injectors market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.